Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

NCT06862869

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China
  • Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou, China
  • Huai He Hospital of Henan University Kaifeng, Henan, China
  • Henan Provincial Chest Hospital Zhengzhou, Henan, China
View all 44 locations
View Trial Details
Recruiting

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

NCT06780085

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Kentucky Chandler Medical Center ( Site 0019) Lexington, Kentucky, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
  • AHN Cancer Institute - Allegheny General ( Site 9501) Pittsburgh, Pennsylvania, United States
  • Centro de Estudios Clínicos SAGA ( Site 0161) Santiago, Region M. de Santiago, Chile
View all 34 locations
View Trial Details
Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

NCT05498428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 110 locations
View Trial Details
Recruiting

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

NCT07230691

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University Hospital Graz Graz, Austria
  • Klinikum Klagenfurt am Worthersee Klagenfurt, Austria
  • UZ Brussel Brussels, Belgium
  • UZ Antwerpen Edegem, Belgium
View all 75 locations
View Trial Details
Recruiting

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

NCT07227025

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of California Irvine Irvine, California, United States
  • New York University Langone Medical Center New York, United States
  • University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
  • Oncology Consultants Cancer Center Houston, Texas, United States
View all 16 locations
View Trial Details
Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

NCT06667908

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View all 43 locations
View Trial Details
Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT06667076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • City of Hope Phoenix Goodyear, Arizona, United States
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
View all 202 locations
View Trial Details
Recruiting

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

NCT06116786

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • City of Hope 1 Newnan, Georgia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Herbert Irving Comprehensive Cancer Center Columbia University Medical Center New York, United States
View all 15 locations
View Trial Details
Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations
  • Stanford Medicine Cancer Center Stanford, California, United States
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 27 locations
View Trial Details

Related conditions